[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2006, 32(4) 214-216 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
�ܰ���
Tϸ��
Ƥ��
���Ʒ�
���������������
�˿���
������
PubMed
Article by GU Jun-ying
Article by CHEN Ming-hua

Ƥ��Tϸ���ܰ����Ĺ��ƽ�չ

�˿���, ������

������ѧ������ɽҽԺƤ����, �Ϻ� 200040

ժҪ��

���ƿ�����Ƥ��Tϸ���ܰ���,���ݲ�ͬ����ѡ�ò�ͬ��Դ.�����в�������ֻ�԰�Ƭ��Ƥ����Ч,խ���в������߶԰�Ƭ�ں����ڰ߿���Ƥ����Ч,����������A1������Ƥ��Ϻ��ֲ������ܲ���֬��,��Ƶ׼���Ӽ���Ԣ�A��Ƥ����Ч.����֬�ӳ���������������߿���Ƥ��,���������û���������Ƥ��Tϸ���ܰ�����Ч�ϼ�.�⶯���Ʒ��������Ƥ��Tϸ���ܰ���.

�ؼ����� �ܰ���   Tϸ��   Ƥ��   ���Ʒ�  

Progress in Phototherapy of Cutaneous T-cell Lymphoma

Department of Dermatology, Hua shah Hospital, Fu dan University, Shanghai 200040, China

Department of Dermatology, Hua shah Hospital, Fu dan University, Shanghai 200040, China

Abstract:

Phototherapy can be used for the treatment of cutaneous T-cell lymphoma (CTCL),and various light sources are choiced according to the stages of the disease.Ultraviolet B(UVB) is exclusively effective for patch-stage lesions,narrowband-ultraviolet B (NB-UVB) for both patch-and plaque-stage lesions.Ultraviolet Al(UVAl) is suitable for those with thicker skin lesions and intolerance to psoralen.Monochromatic excimer laser(308nm) is effective in stage ��A lesions of mycosis fungoides.Ultraviolet A plus psoralen(PUVA) can clear plaque-phase lesions and extracorporeal photopheresis is more effective for advanced CTCL.Photodynamic therapy can also be used in the treatment of CTCL.

Keywords: Lymphoma,T-cell,cutaneous   Phototherapy  
�ո����� 2005-11-16 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] Kulms D,Schwarz T.Independent contribution of three different pathways to ultraviolet-B-induced apoptosis.Biochem Pharmacol,2002,64:837-841.
[2] Baron ED,Stevens SR.Phototherapy for cutaneous T-cell lymphoma.Dermatol Ther,2003,16:303-310.
[3] Apisarnthanarax N,Talpur R,Duvic M.Treatment of cutaneous T cell lymphoma:current status and future directions.Am J Clin Dermatol,2002,3:193-215.
[4] Querfeld C,Rosen ST,Kuzel TM,et al.Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.Arch Dermatol,2005,141:305-311.
[5] Klosner G,Trautinger F,Knobler R,et al.Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Thl to a Th2 response.J Invest Dermatol,2001,116:459-462.
[6] Maeda A,Schwarz A,Kernebeck K,et al.Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells.J Immunol,2005,174:5968-5976.
[7] Schreiner T,Gaczkowski A,Scharffetter-Kochanek K,et al.Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma:a report of 3 cases.Transfus Apher Sci,2005,32:197-203.
[8] Ghodsi SZ,Hallaji Z,Balighi K,et al.Narrow-band UVB in the treatment of early stage mycosis fungoides:report of 16 patients.Clin Exp Dermatol,2005,30:376-378.
[9] Boztepe G,Sahin S,Ayhan M,et al.Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides.J Am Acad Dermatol,2005,53:242-246.
[10] Diederen PV,van Weelden H,Sanders CJ,et al.Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides:a retrospective study.J Am Acad Dermatol,2003,48:215-219.
[11] Breuckmann F,von Kobyletzki G,Avermaete A,et al.Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo:a comparison study.Photodermatol Photoimmunol Photomed,2002,18:217-222.
[12] Zane C,Leali C,Airo P,et al."High-dose" UVA1 therapy of widespread plaque-type,nodular,and erythrodermic mycosis fungoides.J Am Acad Dermatol,2001,44:629-633.
[13] Bianchi B,Campolmi P,Mavilia L,et al.Monochromatic excimer light (308 nm):an immunohistochemical study of cutaneous T cells and apoptosis-related molecules in psoriasis.J Eur Acad Dermatol Venereol,2003,17:408-413.
[14] Nistico S,Costanzo A,Saraceno R,et al.Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides.Br J Dermatol,2004,151:877-879.
[15] Mori M,Campolmi P,Mavilia L,et al.Monochromatic excimer light (308 nm) in patch-stage ��A mycosis fungoides.J Am Acad Dermatol,2004,50:943-945.
[16] Orenstein A,Haik J,Tamir J,et al.Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application.Dermatol Surg,2000,26:765-770.
�������������
1����Ө,֣��.Ƥ��Tϸ���ܰ����ķ��ࡢԤ������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(4): 208-
2���쾧,�浤.�Ƚϻ������ӽ������������Ƥ������[J]. ����Ƥ���Բ�ѧ��־, 2006,32(2): 1024-
3������, �ィ��.�ܰ��������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(6): 360-362
4�������� � ������ ��׿��.Ƥ��CD8+�ױ�Ƥ��Tϸ���ܰ���һ��[J]. ����Ƥ���Բ�ѧ��־, 2009,35(5): 283-284
5���ӻ� �ƻ� ���� ��ϣ�� ��.Ƥ��ĸϸ����NKϸ���ܰ���һ��[J]. ����Ƥ���Բ�ѧ��־, 2009,35(6): 347-348
6��Ҧ��Ӣ ���� ���� ������ ����ü.ԭ����Ƥ������Դ�ϸ���ܰ���һ��[J]. ����Ƥ���Բ�ѧ��־, 2010,36(2): 113-113
7�����ӱ Ƚ��ƽ.ԭ����Ƥ��CD4+������С/��Tϸ���ܰ���һ��[J]. ����Ƥ���Բ�ѧ��־, 2010,36(3): 124-125
8���º� ��ѧ˼ Ѧ���� ������ ���tȺ �ィ��.����������ϸ����ԭ��Ƥ��CD30���Դ�ϸ������ܰ�������[J]. ����Ƥ���Բ�ѧ��־, 2010,36(3): 121-123
9�����ӱ Ƚ��ƽ ���� ����.ԭ����Ƥ�������Դ�Bϸ���ܰ���һ��[J]. ����Ƥ���Բ�ѧ��־, 2010,36(4): 231-231
10����Ծƽ ������.��ʽϸ������ަ����ѿ�׺�S��zary�ۺ����е�Ӧ��[J]. ����Ƥ���Բ�ѧ��־, 2010,36(5): 252-254
11��Bagot M, ���������, ��һԪУ.Ƥ���ܰ�����ϺͲ��������չ[J]. ����Ƥ���Բ�ѧ��־, 1994,20(3): 160-164
12���ƽ����, �ィ����У.����Ƥ��֬Ĥ�׵�Tϸ���ܰ���[J]. ����Ƥ���Բ�ѧ��־, 1997,23(3): 166-169
13�������ٱ���, ���ȼ���У.CD30�ܰ������Լ�����:�ܰ��������������Դ�ϸ���ܰ���[J]. ����Ƥ���Բ�ѧ��־, 1998,24(2): 105-108
14��������, ��ѧ˼.Ƥ��Tϸ���ܰ�����ϵͳҩ������[J]. ����Ƥ���Բ�ѧ��־, 2002,28(2): 76-79
15��������, ����.ԭ����Ƥ��Tϸ���ܰ���[J]. ����Ƥ���Բ�ѧ��־, 2004,30(1): 51-53
16��������, �����.��֯ϸ���������о���״[J]. ����Ƥ���Բ�ѧ��־, 2004,30(5): 317-319
17���쾧, �浤.�Ƚϻ������ӽ������������Ƥ������[J]. ����Ƥ���Բ�ѧ��־, 2006,32(2): 124-126
18������, ������.Ƥ��֬Ĥ����Tϸ���ܰ����о���չ[J]. ����Ƥ���Բ�ѧ��־, 2006,32(5): 294-296
19����һƽ, ¬��÷.TCR����������Ƥ��Tϸ���ܰ����е�Ӧ��[J]. ����Ƥ���Բ�ѧ��־, 2006,32(5): 300-302
20������, �ィ��.�ܰ��������[J]. ����Ƥ���Բ�ѧ��־, 0,(): 360-362
21������ ֣���� �º� ��ǧ�� �Ź���.��ͯ�ܰ����������C�ͣ�һ��[J]. ����Ƥ���Բ�ѧ��־, 2013,39(1): 9-11
22�����Ӹ� �ư�Ƽ ������ ��� ��ʤ.Ƥ��ԭ����B�ܰ�ĸϸ���ܰ���һ��[J]. ����Ƥ���Բ�ѧ��־, 2013,39(1): 7-8
23������, ������.ԭ����Ƥ��CD30+�ܰ�ϸ����ֳ�Լ�����չ[J]. ����Ƥ���Բ�ѧ��־, 2007,33(3): 160-162
24����Ө, ֣��.Ƥ��Tϸ���ܰ����ķ��ࡢԤ������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(4): 208-210
25������ ����ƽ ����� ��С�� ����� ������ ����*.ԭ����Ƥ������Դ�ϸ���ܰ���һ��[J]. ����Ƥ���Բ�ѧ��־, 2014,40(1): 63-63
26����ӱ ������.DNA�׻�����Ƥ���������о���չ[J]. ����Ƥ���Բ�ѧ��־, 2015,41(4): 253-255
27����ϲϲ ³��.Ƥ�������ܰ������о���չ[J]. ����Ƥ���Բ�ѧ��־, 2016,42(6): 457-460

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־